Yuyao Biotech, a biotechnology company founded in 2020, is making strides in healthcare with its innovative AI-driven solutions for hematological tumors, neurodegenerative, and autoimmune diseases. The company's commitment to addressing major unmet clinical drug needs is evident through its integration of artificial intelligence and advanced drug creation technology. Their last investment of CNY90.00M in a Seed Round at 30 December 2022 was backed by LC Ventures, Mingyu Capital, and Intertek Industries. Yuyao Biotech's focus on biopharma and biotechnology industries showcases its dedication to innovation for the betterment of human health.
No recent news or press coverage available for Yuyao Biotech.